HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael P Keane Selected Research

Lung Injury

10/2020Lipid-Laden Macrophages Are Not Diagnostic of Pulmonary Alveolar Proteinosis Syndrome and Can Indicate Lung Injury.
8/2015CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts.
7/2007Keratinocyte growth factor improves repair in the injured tracheal epithelium.
8/2006The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury.
11/2005CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice.
1/2005CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection.
3/2004CXCR2 is critical to hyperoxia-induced lung injury.
12/2002Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael P Keane Research Topics

Disease

20Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2020 - 04/2002
9Fibrosis (Cirrhosis)
11/2018 - 07/2002
9Neoplasms (Cancer)
04/2015 - 06/2003
8Lung Injury
10/2020 - 12/2002
7Lung Neoplasms (Lung Cancer)
01/2022 - 01/2004
7Bronchiolitis Obliterans Syndrome
01/2007 - 02/2002
6Vascular Remodeling
12/2020 - 09/2003
6Neoplasm Metastasis (Metastasis)
04/2006 - 06/2003
5Idiopathic Pulmonary Fibrosis
01/2019 - 09/2003
4Lung Diseases (Lung Disease)
03/2016 - 10/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2005 - 06/2003
3Emphysema
11/2020 - 01/2012
3Infections
10/2020 - 06/2003
3Hypoxia (Hypoxemia)
03/2016 - 06/2005
2Lymphangioleiomyomatosis (Lymphangiomyomatosis)
10/2021 - 11/2010
2Acute Lung Injury
12/2020 - 06/2005
2Bronchiolitis
12/2017 - 02/2002
2Pulmonary Hypertension
03/2016 - 04/2010
2Pneumothorax
01/2012 - 11/2010
2Breast Neoplasms (Breast Cancer)
11/2010 - 06/2003
2Interstitial Lung Diseases (Interstitial Lung Disease)
04/2010 - 08/2007
2Inflammation (Inflammations)
05/2007 - 07/2002
2Carcinogenesis
09/2006 - 03/2004
2Ventilator-Induced Lung Injury
08/2006 - 12/2002
2Virus Diseases (Viral Diseases)
11/2005 - 01/2005
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2005 - 12/2002
1Pulmonary Embolism
01/2022
1Bronchiectasis
11/2020
1Pulmonary Alveolar Proteinosis
10/2020
1COVID-19
10/2020
1Hypotension (Low Blood Pressure)
03/2016
1Wilms Tumor (Wilm's Tumor)
03/2016
1Chronic Obstructive Pulmonary Disease (COPD)
03/2016
1Rheumatoid Arthritis
02/2015
1Asbestosis
02/2015
1Disease Progression
12/2013
1Cutaneous Fistula
02/2012
1Pulmonary Sarcoidosis
04/2011
1Sarcoidosis (Schaumann Disease)
04/2011
1Granuloma
04/2011
1Mediastinal Emphysema (Pneumomediastinum)
11/2010
1Neutropenia
01/2009
1Asthma (Bronchial Asthma)
08/2007
1Pathologic Neovascularization
05/2007

Drug/Important Bio-Agent (IBA)

19CXC ChemokinesIBA
03/2007 - 12/2002
14LigandsIBA
12/2020 - 12/2002
13ChemokinesIBA
04/2011 - 07/2002
9Bleomycin (Blenoxane)FDA LinkGeneric
03/2016 - 04/2002
6Interleukin-13IBA
12/2020 - 10/2002
6Biological ProductsIBA
01/2019 - 06/2003
5CytokinesIBA
05/2007 - 10/2002
5Chemotactic FactorsIBA
11/2005 - 07/2002
3Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2002
3CollagenIBA
11/2018 - 07/2004
3Proteins (Proteins, Gene)FDA Link
03/2016 - 01/2005
3Oxygen (Dioxygen)IBA
03/2016 - 03/2004
3CC ChemokinesIBA
04/2011 - 10/2002
2GadoliniumIBA
11/2020 - 03/2017
2Messenger RNA (mRNA)IBA
03/2016 - 01/2005
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2007 - 10/2002
2Poly CIBA
11/2005 - 01/2005
2CXCR4 Receptors (CXCR4 Receptor)IBA
06/2005 - 06/2003
2Interleukin-7 (Interleukin 7)IBA
07/2004 - 04/2002
2Transforming Growth Factor beta (TGF-beta)IBA
07/2004 - 04/2002
2Interleukin-4 (Interleukin 4)IBA
09/2003 - 10/2002
1fibrin fragment D (D-dimer)IBA
01/2022
1Polysaccharides (Glycans)IBA
01/2022
1Fibrinogen (Factor I)FDA Link
01/2022
1Ga(III)-DOTATOCIBA
10/2021
1CXCR3 ReceptorsIBA
12/2020
1LipidsIBA
10/2020
1tocilizumab (atlizumab)FDA Link
10/2020
1Trp(8)-Cys(14)- somatostatinIBA
12/2017
1chordinIBA
03/2016
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
03/2016
1Activins (Activin)IBA
03/2016
1FollistatinIBA
03/2016
1Vasoconstrictor AgentsIBA
03/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2016
1Vasodilator Agents (Vasodilators)IBA
03/2016
13-(2'-methylphenyl)isocoumarinIBA
04/2015
1Macrophage Migration-Inhibitory FactorsIBA
04/2015
1SmokeIBA
02/2015
1N 30IBA
02/2015
1Toll-Like Receptor 3IBA
12/2013
1ParaffinIBA
02/2012
1ImmunosorbentsIBA
04/2011
1EnzymesIBA
04/2011
1CCR ReceptorsIBA
04/2011
1Fibroblast Growth Factor 7FDA Link
07/2007
1Protective AgentsIBA
07/2007
1Adenosine (Adenocard)FDA LinkGeneric
04/2007

Therapy/Procedure

6Lung Transplantation
04/2010 - 02/2002
5Therapeutics
10/2020 - 06/2003
2Traction
11/2020 - 02/2015
2Artificial Respiration (Mechanical Ventilation)
01/2009 - 08/2006
1Radiofrequency Ablation
02/2012
1Catheters
01/2012
1Pneumonectomy (Lung Volume Reduction)
07/2011
1Drug Therapy (Chemotherapy)
11/2010